Jutta Ackermann

1.4k total citations
24 papers, 970 citations indexed

About

Jutta Ackermann is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Jutta Ackermann has authored 24 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 15 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Jutta Ackermann's work include Multiple Myeloma Research and Treatments (18 papers), Glycosylation and Glycoproteins Research (5 papers) and Protein Degradation and Inhibitors (4 papers). Jutta Ackermann is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Glycosylation and Glycoproteins Research (5 papers) and Protein Degradation and Inhibitors (4 papers). Jutta Ackermann collaborates with scholars based in Austria, Singapore and United States. Jutta Ackermann's co-authors include Johannes Drach, H. Huber, H. Kaufmann, Niklas Zojer, Heinz Gisslinger, Heinz Ludwig, Elisabeth Krömer, R. Heinz, E. Fritz and R. Roka and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Jutta Ackermann

24 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jutta Ackermann Austria	15	705	687	349	214	81	24	970
Christophe Brigaudeau France	11	754 1.1×	646 0.9×	254 0.7×	291 1.4×	91 1.1×	20	939
Zoë J. Konn United Kingdom	10	768 1.1×	681 1.0×	305 0.9×	101 0.5×	102 1.3×	16	978
Margit König Austria	19	667 0.9×	412 0.6×	150 0.4×	137 0.6×	79 1.0×	43	1.1k
HG Ahuja United States	12	538 0.8×	409 0.6×	458 1.3×	313 1.5×	144 1.8×	22	1.1k
Laura Chiecchio United Kingdom	18	1.2k 1.7×	1.2k 1.8×	563 1.6×	201 0.9×	168 2.1×	28	1.6k
Marie‐Paule Mellerin France	14	472 0.7×	415 0.6×	346 1.0×	176 0.8×	150 1.9×	18	871
Nicola Foot United Kingdom	14	481 0.7×	402 0.6×	200 0.6×	213 1.0×	157 1.9×	25	837
Kiyotaka Kashima Japan	8	992 1.4×	499 0.7×	132 0.4×	386 1.8×	71 0.9×	14	1.2k
Maurizio Affer United States	11	401 0.6×	571 0.8×	176 0.5×	92 0.4×	83 1.0×	22	843
Phoenix A. Ho United States	15	876 1.2×	550 0.8×	259 0.7×	149 0.7×	52 0.6×	29	1.2k

Countries citing papers authored by Jutta Ackermann

Since Specialization

Citations

This map shows the geographic impact of Jutta Ackermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jutta Ackermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jutta Ackermann more than expected).

Fields of papers citing papers by Jutta Ackermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jutta Ackermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jutta Ackermann. The network helps show where Jutta Ackermann may publish in the future.

Co-authorship network of co-authors of Jutta Ackermann

This figure shows the co-authorship network connecting the top 25 collaborators of Jutta Ackermann. A scholar is included among the top collaborators of Jutta Ackermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jutta Ackermann. Jutta Ackermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ackermann, Jutta, et al.. (2007). Rapid Remission Induction by VTD (Velcade, Thalidomide, Dexamethason) in Patients with Multiple Myeloma and High Tumor Burden at Diagnosis.. Blood. 110(11). 4845–4845. 3 indexed citations

Drach, Johannes, Verena Sagaster, H. Kaufmann, et al.. (2006). Amplification of 1q21 Is Associated with Poor Outcome after Treatment with Bortezomib in Relapsed/Refractory Multiple Myeloma.. Blood. 108(11). 3398–3398. 2 indexed citations

Sperr, Wolfgang R., Johannes Drach, Alexander W. Hauswirth, et al.. (2005). Myelomastocytic Leukemia: Evidence for the Origin of Mast Cells from the Leukemic Clone and Eradication by Allogeneic Stem Cell Transplantation. Clinical Cancer Research. 11(19). 6787–6792. 35 indexed citations

Drach, Johannes, Verena Sagaster, Niklas Zojer, et al.. (2005). Short Survival, Despite Promising Response Rates, after Bortezomib Treatment of Multiple Myeloma Patients with a 13q-Deletion.. Blood. 106(11). 509–509. 3 indexed citations

Seidl, Sonja, Jutta Ackermann, H. Kaufmann, et al.. (2004). DNA‐methylation analysis identifies the E‐cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies. Cancer. 100(12). 2598–2606. 56 indexed citations

Wöhrer, Stefan, Jutta Ackermann, Sonja Seidl, et al.. (2004). Effective treatment of primary plasma cell leukemia with thalidomide and dexamethasone – a case report. The Hematology Journal. 5(4). 361–363. 10 indexed citations

Kaufmann, H., Elisabeth Krömer, Thomas Nösslinger, et al.. (2003). Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma. European Journal Of Haematology. 71(3). 179–183. 24 indexed citations

Rabitsch, Werner, Erika Prinz, Jutta Ackermann, et al.. (2003). Long‐term follow up of patients with multiple myeloma after high‐dose chemotherapy and allogeneic stem cell transplantation. European Journal Of Haematology. 72(1). 26–31. 6 indexed citations

Schöniger–Hekele, Maximilian, Christian Müller, Jutta Ackermann, et al.. (2002). Lack of Evidence for Involvement of Fetal Microchimerism in Pathogenesis of Primary Biliary Cirrhosis. Digestive Diseases and Sciences. 47(9). 1909–1914. 17 indexed citations

10.

Zojer, Niklas, J. C. Schuster, Jutta Ackermann, et al.. (2002). Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19⁺ cells in patients with myeloma and monoclonal gammopathy of undetermined significance. British Journal of Haematology. 117(4). 852–859. 21 indexed citations

11.

Dekan, Gerhard, Jutta Ackermann, Michael Fiegl, et al.. (2000). Aneuploidy of chromosome 7 can be detected in invasive lung cancer and associated premalignant lesions of the lung by fluorescence in situ hybridisation. Lung Cancer. 28(3). 225–235. 28 indexed citations

12.

Schreiber, S., Jutta Ackermann, Andreas Obermair, et al.. (2000). Multiple myeloma with deletion of chromosome 13q is characterized by increased bone marrow neovascularization. British Journal of Haematology. 110(3). 605–609. 30 indexed citations

13.

Drach, Johannes, et al.. (2000). The biology of multiple myeloma. Journal of Cancer Research and Clinical Oncology. 126(8). 441–447. 37 indexed citations

14.

Königsberg, Robert, Niklas Zojer, Jutta Ackermann, et al.. (2000). Predictive Role of Interphase Cytogenetics for Survival of Patients With Multiple Myeloma. Journal of Clinical Oncology. 18(4). 804–804. 115 indexed citations

15.

Zojer, Niklas, Robert Königsberg, Jutta Ackermann, et al.. (2000). Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood. 95(6). 1925–1930. 226 indexed citations

16.

Drach, Johannes, et al.. (2000). The biology of multiple myeloma. Journal of Cancer Research and Clinical Oncology. 126(8). 441–447. 27 indexed citations

17.

Zojer, Niklas, Johannes Meran, Michael Vesely, et al.. (1999). Trisomy 13 is Associated with Poor Prognosis in Idiopathic Myelofibrosis with Myeloid Metaplasia. Leukemia & lymphoma. 35(3-4). 415–421. 5 indexed citations

18.

Ackermann, Jutta, Niklas Zojer, Heinz Gisslinger, et al.. (1998). Absence of p53 deletions in bone marrow plasma cells of patients with monoclonal gammopathy of undedetermined significance. British Journal of Haematology. 103(4). 1161–1163. 18 indexed citations

19.

Drach, Johannes, Markus Raderer, Ichiro Okamoto, et al.. (1998). Cytogenetic Analysis and Fluorescence In Situ Hybridization in a Case of IgD Multiple Myeloma. Cancer Genetics and Cytogenetics. 105(2). 172–176. 1 indexed citations

20.

Schenk, Thomas, Jutta Ackermann, Christoph Brunner, et al.. (1997). Detection of Chromosomal Aneuploidy by Interphase Fluorescence In Situ Hybridization in Bronchoscopically Gained Cells From Lung Cancer Patients. CHEST Journal. 111(6). 1691–1696. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact